Abstract
Summary
Solid phase peptide synthesis (SPPS) is a technique for peptide synthesis. It can be defined as a process in which a peptide anchored by its c-terminus to an insoluble polymer is assembled by the successive addition of the protected amino acids constituting its sequence.
The global Solid-Phase Peptide Synthesis (SPPS) Service market size is projected to grow from US$ 149.7 million in 2023 to US$ 203.1 million in 2030; it is expected to grow at a CAGR of 4.5% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Solid-Phase Peptide Synthesis (SPPS) Service Industry Forecast” looks at past sales and reviews total world Solid-Phase Peptide Synthesis (SPPS) Service sales in 2023, providing a comprehensive analysis by region and market sector of projected Solid-Phase Peptide Synthesis (SPPS) Service sales for 2024 through 2030. With Solid-Phase Peptide Synthesis (SPPS) Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Solid-Phase Peptide Synthesis (SPPS) Service industry.
This Insight Report provides a comprehensive analysis of the global Solid-Phase Peptide Synthesis (SPPS) Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Solid-Phase Peptide Synthesis (SPPS) Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Solid-Phase Peptide Synthesis (SPPS) Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Solid-Phase Peptide Synthesis (SPPS) Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Solid-Phase Peptide Synthesis (SPPS) Service.
United States market for Solid-Phase Peptide Synthesis (SPPS) Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Solid-Phase Peptide Synthesis (SPPS) Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Solid-Phase Peptide Synthesis (SPPS) Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Solid-Phase Peptide Synthesis (SPPS) Service players cover Bachem, PolyPeptide, CordenPharma, AmbioPharm and USV Peptides, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Solid-Phase Peptide Synthesis (SPPS) Service market by product type, application, key players and key regions and countries.
Segmentation by type
GMP Services
Non-GMP Services
Segmentation by application
Commercial
Scientific Research
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
AnaSpec
The global Solid-Phase Peptide Synthesis (SPPS) Service market size is projected to grow from US$ 149.7 million in 2023 to US$ 203.1 million in 2030; it is expected to grow at a CAGR of 4.5% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Solid-Phase Peptide Synthesis (SPPS) Service Industry Forecast” looks at past sales and reviews total world Solid-Phase Peptide Synthesis (SPPS) Service sales in 2023, providing a comprehensive analysis by region and market sector of projected Solid-Phase Peptide Synthesis (SPPS) Service sales for 2024 through 2030. With Solid-Phase Peptide Synthesis (SPPS) Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Solid-Phase Peptide Synthesis (SPPS) Service industry.
This Insight Report provides a comprehensive analysis of the global Solid-Phase Peptide Synthesis (SPPS) Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Solid-Phase Peptide Synthesis (SPPS) Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Solid-Phase Peptide Synthesis (SPPS) Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Solid-Phase Peptide Synthesis (SPPS) Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Solid-Phase Peptide Synthesis (SPPS) Service.
United States market for Solid-Phase Peptide Synthesis (SPPS) Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Solid-Phase Peptide Synthesis (SPPS) Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Solid-Phase Peptide Synthesis (SPPS) Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Solid-Phase Peptide Synthesis (SPPS) Service players cover Bachem, PolyPeptide, CordenPharma, AmbioPharm and USV Peptides, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Solid-Phase Peptide Synthesis (SPPS) Service market by product type, application, key players and key regions and countries.
Segmentation by type
GMP Services
Non-GMP Services
Segmentation by application
Commercial
Scientific Research
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
AnaSpec
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Solid-Phase Peptide Synthesis (SPPS) Service Market Size 2019-2030
2.1.2 Solid-Phase Peptide Synthesis (SPPS) Service Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Solid-Phase Peptide Synthesis (SPPS) Service Segment by Type
2.2.1 GMP Services
2.2.2 Non-GMP Services
2.3 Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Type
2.3.1 Solid-Phase Peptide Synthesis (SPPS) Service Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Solid-Phase Peptide Synthesis (SPPS) Service Market Size Market Share by Type (2019-2024)
2.4 Solid-Phase Peptide Synthesis (SPPS) Service Segment by Application
2.4.1 Commercial
2.4.2 Scientific Research
2.4.3 Other
2.5 Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Application
2.5.1 Solid-Phase Peptide Synthesis (SPPS) Service Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Solid-Phase Peptide Synthesis (SPPS) Service Market Size Market Share by Application (2019-2024)
3 Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Player
3.1 Solid-Phase Peptide Synthesis (SPPS) Service Market Size Market Share by Players
3.1.1 Global Solid-Phase Peptide Synthesis (SPPS) Service Revenue by Players (2019-2024)
3.1.2 Global Solid-Phase Peptide Synthesis (SPPS) Service Revenue Market Share by Players (2019-2024)
3.2 Global Solid-Phase Peptide Synthesis (SPPS) Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Solid-Phase Peptide Synthesis (SPPS) Service by Regions
4.1 Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Regions (2019-2024)
4.2 Americas Solid-Phase Peptide Synthesis (SPPS) Service Market Size Growth (2019-2024)
4.3 APAC Solid-Phase Peptide Synthesis (SPPS) Service Market Size Growth (2019-2024)
4.4 Europe Solid-Phase Peptide Synthesis (SPPS) Service Market Size Growth (2019-2024)
4.5 Middle East & Africa Solid-Phase Peptide Synthesis (SPPS) Service Market Size Growth (2019-2024)
5 Americas
5.1 Americas Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Country (2019-2024)
5.2 Americas Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Type (2019-2024)
5.3 Americas Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Region (2019-2024)
6.2 APAC Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Type (2019-2024)
6.3 APAC Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Solid-Phase Peptide Synthesis (SPPS) Service by Country (2019-2024)
7.2 Europe Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Type (2019-2024)
7.3 Europe Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Solid-Phase Peptide Synthesis (SPPS) Service by Region (2019-2024)
8.2 Middle East & Africa Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Type (2019-2024)
8.3 Middle East & Africa Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.1 Global Solid-Phase Peptide Synthesis (SPPS) Service Forecast by Regions (2025-2030)
10.1.1 Global Solid-Phase Peptide Synthesis (SPPS) Service Forecast by Regions (2025-2030)
10.1.2 Americas Solid-Phase Peptide Synthesis (SPPS) Service Forecast
10.1.3 APAC Solid-Phase Peptide Synthesis (SPPS) Service Forecast
10.1.4 Europe Solid-Phase Peptide Synthesis (SPPS) Service Forecast
10.1.5 Middle East & Africa Solid-Phase Peptide Synthesis (SPPS) Service Forecast
10.2 Americas Solid-Phase Peptide Synthesis (SPPS) Service Forecast by Country (2025-2030)
10.2.1 United States Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.2.2 Canada Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.2.3 Mexico Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.2.4 Brazil Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.3 APAC Solid-Phase Peptide Synthesis (SPPS) Service Forecast by Region (2025-2030)
10.3.1 China Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.3.2 Japan Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.3.3 Korea Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.3.4 Southeast Asia Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.3.5 India Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.3.6 Australia Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.4 Europe Solid-Phase Peptide Synthesis (SPPS) Service Forecast by Country (2025-2030)
10.4.1 Germany Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.4.2 France Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.4.3 UK Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.4.4 Italy Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.4.5 Russia Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.5 Middle East & Africa Solid-Phase Peptide Synthesis (SPPS) Service Forecast by Region (2025-2030)
10.5.1 Egypt Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.5.2 South Africa Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.5.3 Israel Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.5.4 Turkey Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.5.5 GCC Countries Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast
10.6 Global Solid-Phase Peptide Synthesis (SPPS) Service Forecast by Type (2025-2030)
10.7 Global Solid-Phase Peptide Synthesis (SPPS) Service Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Bachem
11.1.1 Bachem Company Information
11.1.2 Bachem Solid-Phase Peptide Synthesis (SPPS) Service Product Offered
11.1.3 Bachem Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bachem Main Business Overview
11.1.5 Bachem Latest Developments
11.2 PolyPeptide
11.2.1 PolyPeptide Company Information
11.2.2 PolyPeptide Solid-Phase Peptide Synthesis (SPPS) Service Product Offered
11.2.3 PolyPeptide Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 PolyPeptide Main Business Overview
11.2.5 PolyPeptide Latest Developments
11.3 CordenPharma
11.3.1 CordenPharma Company Information
11.3.2 CordenPharma Solid-Phase Peptide Synthesis (SPPS) Service Product Offered
11.3.3 CordenPharma Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 CordenPharma Main Business Overview
11.3.5 CordenPharma Latest Developments
11.4 AmbioPharm
11.4.1 AmbioPharm Company Information
11.4.2 AmbioPharm Solid-Phase Peptide Synthesis (SPPS) Service Product Offered
11.4.3 AmbioPharm Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 AmbioPharm Main Business Overview
11.4.5 AmbioPharm Latest Developments
11.5 USV Peptides
11.5.1 USV Peptides Company Information
11.5.2 USV Peptides Solid-Phase Peptide Synthesis (SPPS) Service Product Offered
11.5.3 USV Peptides Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 USV Peptides Main Business Overview
11.5.5 USV Peptides Latest Developments
11.6 Thermofischer
11.6.1 Thermofischer Company Information
11.6.2 Thermofischer Solid-Phase Peptide Synthesis (SPPS) Service Product Offered
11.6.3 Thermofischer Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Thermofischer Main Business Overview
11.6.5 Thermofischer Latest Developments
11.7 Bio Basic
11.7.1 Bio Basic Company Information
11.7.2 Bio Basic Solid-Phase Peptide Synthesis (SPPS) Service Product Offered
11.7.3 Bio Basic Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bio Basic Main Business Overview
11.7.5 Bio Basic Latest Developments
11.8 JPT
11.8.1 JPT Company Information
11.8.2 JPT Solid-Phase Peptide Synthesis (SPPS) Service Product Offered
11.8.3 JPT Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 JPT Main Business Overview
11.8.5 JPT Latest Developments
11.9 Genscript
11.9.1 Genscript Company Information
11.9.2 Genscript Solid-Phase Peptide Synthesis (SPPS) Service Product Offered
11.9.3 Genscript Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Genscript Main Business Overview
11.9.5 Genscript Latest Developments
11.10 Xinbang Pharma
11.10.1 Xinbang Pharma Company Information
11.10.2 Xinbang Pharma Solid-Phase Peptide Synthesis (SPPS) Service Product Offered
11.10.3 Xinbang Pharma Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Xinbang Pharma Main Business Overview
11.10.5 Xinbang Pharma Latest Developments
11.11 ScinoPharm
11.11.1 ScinoPharm Company Information
11.11.2 ScinoPharm Solid-Phase Peptide Synthesis (SPPS) Service Product Offered
11.11.3 ScinoPharm Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 ScinoPharm Main Business Overview
11.11.5 ScinoPharm Latest Developments
11.12 SN Biopharm
11.12.1 SN Biopharm Company Information
11.12.2 SN Biopharm Solid-Phase Peptide Synthesis (SPPS) Service Product Offered
11.12.3 SN Biopharm Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 SN Biopharm Main Business Overview
11.12.5 SN Biopharm Latest Developments
11.13 CBL
11.13.1 CBL Company Information
11.13.2 CBL Solid-Phase Peptide Synthesis (SPPS) Service Product Offered
11.13.3 CBL Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 CBL Main Business Overview
11.13.5 CBL Latest Developments
11.14 Piramal Pharma
11.14.1 Piramal Pharma Company Information
11.14.2 Piramal Pharma Solid-Phase Peptide Synthesis (SPPS) Service Product Offered
11.14.3 Piramal Pharma Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Piramal Pharma Main Business Overview
11.14.5 Piramal Pharma Latest Developments
11.15 CPC Scientific
11.15.1 CPC Scientific Company Information
11.15.2 CPC Scientific Solid-Phase Peptide Synthesis (SPPS) Service Product Offered
11.15.3 CPC Scientific Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 CPC Scientific Main Business Overview
11.15.5 CPC Scientific Latest Developments
11.16 AnaSpec
11.16.1 AnaSpec Company Information
11.16.2 AnaSpec Solid-Phase Peptide Synthesis (SPPS) Service Product Offered
11.16.3 AnaSpec Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 AnaSpec Main Business Overview
11.16.5 AnaSpec Latest Developments
12 Research Findings and Conclusion